Bank of America’s ImmuCell ICCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,040
Closed -$12.5K 6256
2025
Q4
$12.5K Hold
2,040
﹤0.01% 6120
2025
Q3
$12.8K Sell
2,040
-55
-3% -$348 ﹤0.01% 7156
2025
Q2
$14.6K Buy
2,095
+8
+0.4% +$47 ﹤0.01% 7116
2025
Q1
$10K Buy
2,087
+2
+0.1% +$10 ﹤0.01% 7112
2024
Q4
$10.7K Buy
2,085
+7
+0.3% +$28 ﹤0.01% 6966
2024
Q3
$7.54K Buy
2,078
+1
+0% +$4 ﹤0.01% 6942
2024
Q2
$10.1K Buy
2,077
+45
+2% +$217 ﹤0.01% 6894
2024
Q1
$10.8K Sell
2,032
-3
-0.1% -$15 ﹤0.01% 6874
2023
Q4
$10.4K Buy
2,035
+3
+0.1% +$15 ﹤0.01% 6902
2023
Q3
$10.8K Hold
2,032
﹤0.01% 6842
2023
Q2
$10.2K Hold
2,032
﹤0.01% 6859
2023
Q1
$10.4K Sell
2,032
-6
-0.3% -$39 ﹤0.01% 6908
2022
Q4
$12.4K Buy
2,038
+6
+0.3% +$43 ﹤0.01% 6869
2022
Q3
$15K Hold
2,032
﹤0.01% 7124
2022
Q2
$17K Hold
2,032
﹤0.01% 7227
2022
Q1
$20K Sell
2,032
-10
-0.5% -$86 ﹤0.01% 7514
2021
Q4
$16K Sell
2,042
-19
-0.9% -$170 ﹤0.01% 7581
2021
Q3
$19K Buy
2,061
+29
+1% +$274 ﹤0.01% 7402
2021
Q2
$20K Sell
2,032
-22
-1% -$215 ﹤0.01% 7129
2021
Q1
$20K Buy
2,054
+22
+1% +$206 ﹤0.01% 6884
2020
Q4
$12K Sell
2,032
-32
-2% -$186 ﹤0.01% 6685
2020
Q3
$11K Sell
2,064
-5
-0.2% -$28 ﹤0.01% 6429
2020
Q2
$9K Buy
2,069
+37
+2% +$161 ﹤0.01% 6466
2020
Q1
$8K Sell
2,032
-980
-33% -$4.82K ﹤0.01% 6414
2019
Q4
$16K Sell
3,012
-42
-1% -$217 ﹤0.01% 6544
2019
Q3
$17K Sell
3,054
-27
-0.9% -$158 ﹤0.01% 6615
2019
Q2
$20K Buy
3,081
+69
+2% +$438 ﹤0.01% 6565
2019
Q1
$19K Sell
3,012
-4
-0.1% -$29 ﹤0.01% 6507
2018
Q4
$21K Sell
3,016
-127
-4% -$982 ﹤0.01% 6477
2018
Q3
$26K Buy
3,143
+1,108
+54% +$7.97K ﹤0.01% 6425
2018
Q2
$13K Buy
2,035
+3
+0.1% +$22 ﹤0.01% 6601
2018
Q1
$15K Hold
2,032
﹤0.01% 6477
2017
Q4
$17K Sell
2,032
-15
-0.7% -$123 ﹤0.01% 6463
2017
Q3
$13K Buy
2,047
+15
+0.7% +$98 ﹤0.01% 6444
2017
Q2
$15K Hold
2,032
﹤0.01% 6305
2017
Q1
$11K Hold
2,032
﹤0.01% 6516
2016
Q4
$12K Sell
2,032
-213
-9% -$1.3K ﹤0.01% 6497
2016
Q3
$18K Buy
2,245
+213
+10% +$1.55K ﹤0.01% 6170
2016
Q2
$14K Hold
2,032
﹤0.01% 6386
2016
Q1
$13K Hold
2,032
﹤0.01% 6296
2015
Q4
$16K Hold
2,032
﹤0.01% 6509
2015
Q3
$12K Hold
2,032
﹤0.01% 6500
2015
Q2
$16K Hold
2,032
﹤0.01% 6422
2015
Q1
$13K Hold
2,032
﹤0.01% 6214
2014
Q4
$9K Hold
2,032
﹤0.01% 7102
2014
Q3
$10K Sell
2,032
-42
-2% -$196 ﹤0.01% 7318
2014
Q2
$9K Buy
2,074
+42
+2% +$177 ﹤0.01% 7500
2014
Q1
$9K Sell
2,032
-4
-0.2% -$17 ﹤0.01% 7211
2013
Q4
$9K Buy
2,036
+4
+0.2% +$17 ﹤0.01% 7318
2013
Q3
$9K Hold
2,032
﹤0.01% 7199
2013
Q2
$8K Buy
+2,032
New +$7.28K ﹤0.01% 7227

Other funds holding ICCC

Bank of America's ICCC Position: Q1 2026 in Review

Bank of America sold out of ImmuCell (ICCC) in Q1 2026, closing a stake of 2,040 shares — an estimated $12.5K sold.

Bank of America first reported a position in ICCC in Q2 2013 and held it in 51 quarters. The position peaked at $26K in Q3 2018. 27 funds tracked by Wall St. Rank hold ICCC as of Q1 2026.

  • Bank of America reported no remaining ImmuCell position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 2,040 ImmuCell shares in Q1 2026, an estimated $12.5K.
  • Bank of America first reported a position in ImmuCell in Q2 2013 and held it in 51 quarters.
  • Bank of America's ImmuCell position peaked at $26K in Q3 2018.
  • 27 funds tracked by Wall St. Rank held ImmuCell as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.